Lakewood-Amedex Biotherapeutics IncLABT
Price$0.93

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Margins

Current

Balance Sheet Health

Current Ratio7.70x
Cash & Equivalents$2.6M

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Bisphosphocin Antimicrobials$0
View details

Planning Phase 2a safety/dose and Phase 2b dose-comparison studies.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.